196 related articles for article (PubMed ID: 29273686)
1. Ovarian aging is associated with gray matter volume and disability in women with MS.
Graves JS; Henry RG; Cree BAC; Lambert-Messerlian G; Greenblatt RM; Waubant E; Cedars MI; Zhu A; ; Bacchetti P; Hauser SL; Oksenberg JR
Neurology; 2018 Jan; 90(3):e254-e260. PubMed ID: 29273686
[TBL] [Abstract][Full Text] [Related]
2. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Khalid F; Tauhid S; Chua AS; Healy BC; Stankiewicz JM; Weiner HL; Bakshi R
Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up.
Murali N; Browne RW; Fellows Maxwell K; Bodziak ML; Jakimovski D; Hagemeier J; Bergsland N; Weinstock-Guttman B; Zivadinov R; Ramanathan M
Eur J Neurol; 2020 Jan; 27(1):188-e4. PubMed ID: 31369181
[TBL] [Abstract][Full Text] [Related]
5. Adult brain volume in multiple sclerosis: The impact of paediatric onset.
Fenu G; Lorefice L; Loi L; Sechi V; Contu F; Coghe G; Frau J; Spinicci G; Barracciu MA; Marrosu MG; Cocco E
Mult Scler Relat Disord; 2018 Apr; 21():103-107. PubMed ID: 29544192
[TBL] [Abstract][Full Text] [Related]
6. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition.
Yang YS; Hur MH; Kim SY; Young K
Menopause; 2011 Feb; 18(2):138-45. PubMed ID: 21341396
[TBL] [Abstract][Full Text] [Related]
7. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
[TBL] [Abstract][Full Text] [Related]
8. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline.
de Kat AC; van der Schouw YT; Eijkemans MJ; Herber-Gast GC; Visser JA; Verschuren WM; Broekmans FJ
BMC Med; 2016 Oct; 14(1):151. PubMed ID: 27716302
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
10. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M
JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955
[TBL] [Abstract][Full Text] [Related]
11. Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.
Krysko KM; Henry RG; Cree BAC; Lin J; ; Caillier S; Santaniello A; Zhao C; Gomez R; Bevan C; Smith DL; Stern W; Kirkish G; Hauser SL; Oksenberg JR; Graves JS
Ann Neurol; 2019 Nov; 86(5):671-682. PubMed ID: 31486104
[TBL] [Abstract][Full Text] [Related]
12. Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.
Bsteh G; Steiger R; Tuovinen N; Hegen H; Berek K; Wurth S; Auer M; Di Pauli F; Gizewski ER; Deisenhammer F; Berger T; Scherfler C
Mult Scler; 2020 May; 26(6):706-715. PubMed ID: 30895860
[TBL] [Abstract][Full Text] [Related]
13. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.
Opfer R; Krüger J; Spies L; Hamann M; Wicki CA; Kitzler HH; Gocke C; Silva D; Schippling S
Neuroimage Clin; 2020; 28():102478. PubMed ID: 33269702
[TBL] [Abstract][Full Text] [Related]
16. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
17. Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
MacKenzie-Graham A; Kurth F; Itoh Y; Wang HJ; Montag MJ; Elashoff R; Voskuhl RR
JAMA Neurol; 2016 Aug; 73(8):944-53. PubMed ID: 27294295
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
19. Frequency of diminished ovarian reserve in women with multiple sclerosis in Chile: An exploratory study.
Pelayo C; Ciampi E; Soler B; Uribe-San-Martín R; Reyes A; García L; Del-Canto A; Gutierrez-Carquin L; Barrerra-Hormazabal A; Jürgensen-Heinrich L; Guzman-Cárcamo I; Carvajal A; Troncoso C; Carvajal R; Cárcamo C
Mult Scler Relat Disord; 2023 Nov; 79():105012. PubMed ID: 37797392
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women.
Şenateş E; Çolak Y; Erdem ED; Yeşil A; Coşkunpınar E; Şahin Ö; Altunöz ME; Tuncer I; Kurdaş Övünç AO
J Crohns Colitis; 2013 Mar; 7(2):e29-34. PubMed ID: 22472089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
